Edition:
India

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

3.97USD
7 Aug 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.97
Open
--
Day's High
--
Day's Low
--
Volume
8,290
Avg. Vol
2,038,922
52-wk High
$6.28
52-wk Low
$1.38

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.23 December 10 Aug 2020

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 4 4 5 5
(3) HOLD 2 2 1 1
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.22 2.22 2.11 2.11

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-20 8 6.30 22.06 0.00 5.00
Quarter Ending Dec-20 8 15.79 29.99 2.20 5.00
Year Ending Dec-20 9 28.69 40.56 11.00 37.62
Year Ending Dec-21 9 55.28 111.08 21.23 43.80
Earnings (per share)
Quarter Ending Sep-20 9 -0.23 -0.12 -0.31 -0.35
Quarter Ending Dec-20 9 -0.17 -0.06 -0.31 -0.30
Year Ending Dec-20 9 -0.90 -0.74 -1.15 -1.08
Year Ending Dec-21 9 -0.75 -0.39 -1.15 -1.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-20 4.29 4.82 0.53 12.41
Quarter Ending Dec-19 9.88 39.72 29.85 302.23
Quarter Ending Sep-19 2.96 1.77 1.19 40.13
Quarter Ending Jun-19 2.02 1.45 0.57 28.31
Quarter Ending Mar-19 3.11 5.89 2.78 89.29

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-20 6.30 6.30 6.30 6.33 5.00
Quarter Ending Dec-20 15.79 15.79 15.79 16.56 5.00
Year Ending Dec-20 28.69 28.69 28.69 29.67 37.62
Year Ending Dec-21 55.28 55.28 55.28 61.56 43.80

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-20 0 0 0 0
Quarter Ending Dec-20 0 0 0 0
Year Ending Dec-20 0 0 0 0
Year Ending Dec-21 0 0 0 0
Earnings